-
VERAXA Biotech
Created in 2021
-
-
Up & running (A)
Existing signals show a regular activity -
Social networks
4,922 -
Activities
-
Technologies
-
Entity types
-
Location
Im Neuenheimer Feld 584, 69120 Heidelberg, Germany
Heidelberg
Germany
-
Employees
Scale: 11-50
Estimated: 47
-
Engaged catalyst
1
0 0 -
Added in Motherbase
1 month, 3 weeks ago
-
Value proposition
Pioneering Antibody Innovations to Defeat Cancer
At VERAXA Biotech (NASDAQ:VRXA), we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including antibody-drug conjugates (ADCs), bispecific T cell engagers (BiTAC TCEs), and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond.
VERAXA Biotech was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technologies.
Cancer Research, Drug Development, Bispecifics, TCEs, ADCs, and BiTAC
-
Superior Cancer Therapeutics Using Transformative Innovations
At VERAXA Biotech, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics.
https://veraxa.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Biotechnology Innovation Organization
Biotechnology Research (Auto) |
Biotechnology Innovation Organization
Biotechnology Research (Auto) |
Other
31 May 2026 |
|
|